JPWO2025023252A1 - - Google Patents

Info

Publication number
JPWO2025023252A1
JPWO2025023252A1 JP2025535840A JP2025535840A JPWO2025023252A1 JP WO2025023252 A1 JPWO2025023252 A1 JP WO2025023252A1 JP 2025535840 A JP2025535840 A JP 2025535840A JP 2025535840 A JP2025535840 A JP 2025535840A JP WO2025023252 A1 JPWO2025023252 A1 JP WO2025023252A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2025535840A
Other languages
Japanese (ja)
Other versions
JP7780235B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2025023252A1 publication Critical patent/JPWO2025023252A1/ja
Application granted granted Critical
Publication of JP7780235B2 publication Critical patent/JP7780235B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/24Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
    • C07C49/245Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K15/00Anti-oxidant compositions; Compositions inhibiting chemical change
    • C09K15/04Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds
    • C09K15/06Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing oxygen
    • C09K15/08Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing oxygen containing a phenol or quinone moiety

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2025535840A 2023-07-24 2024-07-23 抗酸化化合物 Active JP7780235B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023119682 2023-07-24
JP2023119682 2023-07-24
PCT/JP2024/026351 WO2025023252A1 (ja) 2023-07-24 2024-07-23 抗酸化化合物

Publications (2)

Publication Number Publication Date
JPWO2025023252A1 true JPWO2025023252A1 (https=) 2025-01-30
JP7780235B2 JP7780235B2 (ja) 2025-12-04

Family

ID=94375332

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025535840A Active JP7780235B2 (ja) 2023-07-24 2024-07-23 抗酸化化合物

Country Status (2)

Country Link
JP (1) JP7780235B2 (https=)
WO (1) WO2025023252A1 (https=)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57114509A (en) * 1981-01-07 1982-07-16 Eisai Co Ltd Remedy for diabetic cataract
JP2000319154A (ja) * 1999-05-06 2000-11-21 Nippon Menaade Keshohin Kk 光毒性抑制剤
JP2005510503A (ja) * 2001-10-25 2005-04-21 ノボゲン リサーチ ピーティーワイ リミテッド 6−ヒドロキシイソフラボン、誘導体及びそれを含む薬剤
JP2006016343A (ja) * 2004-07-02 2006-01-19 National Institute Of Advanced Industrial & Technology 皮膚外用剤

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57114509A (en) * 1981-01-07 1982-07-16 Eisai Co Ltd Remedy for diabetic cataract
JP2000319154A (ja) * 1999-05-06 2000-11-21 Nippon Menaade Keshohin Kk 光毒性抑制剤
JP2005510503A (ja) * 2001-10-25 2005-04-21 ノボゲン リサーチ ピーティーワイ リミテッド 6−ヒドロキシイソフラボン、誘導体及びそれを含む薬剤
JP2006016343A (ja) * 2004-07-02 2006-01-19 National Institute Of Advanced Industrial & Technology 皮膚外用剤

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF THE CHEMICAL SOCIETY, JPN6025046100, 1 January 1965 (1965-01-01), pages 3040 - 3044, ISSN: 0005729389 *
SAHIN, KADER ET AL.: "Identifying the Novel Pyrimidine-Based CDK2 Inhibitors as Anticancer Agents Using Text-Mining and Co", JOURNAL OF THE TURKISH CHEMICAL SOCIETY SECTION A: CHEMISTRY, vol. 7, no. 2, JPN6020045851, 23 June 2020 (2020-06-23), pages 383 - 404, ISSN: 0005729388 *

Also Published As

Publication number Publication date
JP7780235B2 (ja) 2025-12-04
WO2025023252A1 (ja) 2025-01-30

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
CA3257050A1 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001987A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BY13161U (https=)
BY13156U (https=)
CN307045197S (https=)
CN307044670S (https=)
CN307047157S (https=)
CN307047494S (https=)
BY23968C1 (https=)
CN307047666S (https=)
CN307047673S (https=)
BY13168U (https=)
BY13166U (https=)
BY13165U (https=)
CN307047722S (https=)
BY13164U (https=)
BY13163U (https=)
BY13162U (https=)
BY13150U (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250527

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20251111

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20251114

R150 Certificate of patent or registration of utility model

Ref document number: 7780235

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150